Logo_AIHTA
  • Deutsch
  • Contact
    • Imprint
      • Privacy Notice
        • Newsletter
          • Sitemap
            Menu_button
            • News
              • About us
                • Research areas
                  • Research Projects
                    • Publications
                      • Search
                        • Announcements
                          • Events
                            • Newsletter
                              • Press photos
                                Video
                                Video: What is HTA?    
                                • Home
                                • News

                                News

                                Fotoleiste-2


                                Welcome to the homepage of AIHTA!

                                AIHTA is an acadmic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                Subscribe to newsletter

                                Adobestock-206338397-elenabsl1
                                ©elenabsl

                                Announcement

                                Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples

                                Digital health applications have the potential to improve disease monitoring and management. For the majority of available digital health applications, however, there is little evidence of (medical, organizational or economic) benefit. The thorough evaluation of a digital health application requires additional technology-specific domains. Decision-makers are thus faced with new challenges in the evaluation of these applications.

                                The aim of this report was to provide guidance to funding institutions and manufacturers as to what evidence is expected for which type of digital health application. For this purpose, the applicability of currently available assessment frameworks for digital health applications was examined.

                                Publication: HTA Projektbericht No. 134: https://eprints.aihta.at/1279
                                Contact: Reinhard Jeindl, Claudia Wild
                                 

                                More...

                                2149
                                ©Juan Gärtner

                                Announcement

                                Horizon Scanning in Oncology - Fact Sheets

                                We are pleased to introduce our three new HSO Fact Sheets.

                                Fact Sheet No. 25 (October 2020)
                                Blinatumomab (Blincyto®) for the treatment of patients with Philadelphia chromosome positive B-precursor acute lymphoblastic leukaemia (ALL)

                                Fact Sheet No. 26 (October 2020)
                                Nivolumab (Opdivo®) as monotherapy for the treatment of unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (OESCC)

                                Fact Sheet No. 27 (October 2020)
                                Autologous anti-CD19-transduced CD3+ cells (Tecartus®) for the treatment of relapsed or refractory mantle cell lymphoma (MCL)

                                More...

                                Adobestock-329115246-von-mike-fouque-klein8
                                @ Mike Fouque

                                Announcement

                                Covid-19: HSS/ Horizon Scanning Living Document (v08 November 2020)

                                The establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary. The products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.

                                All work steps are conducted in close international (European) cooperation.

                                Publications: 

                                • Policy Brief No. 002: http://eprints.aihta.at/1234/

                                Contact: Claudia Wild

                                More...

                                Newsletter_preview

                                Newsletter

                                Note: this content is only available in German.

                                Inhalt

                                • Editorial: Klinische Covid-19-Plattform-Studien und neue Rolle von HTA
                                • Musiktherapie bei Autismus, Demenz, Depression, Schlafstörung und Schizophrenie
                                • Vitamin D3 zur Immunmodulation bei Covid-19
                                • Home-Treatment in der Kinder- und Jugendpsychiatrie
                                • Molekulargenetische Diagnostik der Familiäreren Hypercholesterinämie
                                • Termine
                                • Themen-Vorschau
                                Print Zur Druckversion...
                                Kj
                                ©AungMyo

                                Announcement

                                Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria

                                The Austrian child and adolescent psychiatric care landscape is characterised by substantial deficits on the intramural, as well as, on the extramural level. To overcome these supply shortfalls alternative outreach approaches, such as home-treatment, can be introduced to facilitate the reduction of hospitalisations. In this context, the present report aimed to systematically characterise international home-treatment-models considering their effectiveness and safety in the area of child and adolescent psychiatry. In addition, the fundamental challenges of implementing such treatment approaches were examined, taking into account the current Austrian care situation.

                                Publication: AIHTA Project report No. 129: http://eprints.aihta.at/1275/

                                Contact: Sarah Wolf, Nicole Grössmann

                                More...

                                2148
                                ©Juan Gärtner

                                Announcement

                                Horizon Scanning in Oncology - Fact Sheets

                                We are pleased to introduce our five new HSO Fact Sheets.

                                Fact Sheet No. 20 (September 2020)
                                Atezolizumab (Tecentriq®) plus bevacizumab for the treatment of advanced or unresectable hepatocellular carcinoma (HCC)

                                Fact Sheet No. 21 (September 2020)
                                Nivolumab (Opdivo®) plus ipilimumab (Yervoy®) and chemotherapy as first-line treatment for metastatic non-small cell lung cancer (NSCLC)

                                Fact Sheet No. 22 (September 2020)
                                Niraparib (Zejula®) in patients with newly diagnosed advanced ovarian cancer

                                Fact Sheet No. 23 (September 2020)
                                Olaparib (Lynparza®) for metastatic castration-resistant prostate cancer (mCRPC)

                                Fact Sheet No. 24 (September 2020)
                                Olaparib (Lynparza®) plus bevacizumab as first-line maintenance treatment in patients with ovarian cancer

                                More...

                                Newsletter_preview

                                Newsletter

                                Note: this content is only available in German.

                                Inhalt

                                • Editorial: Volume-Outcome Beziehung: Barmer Krankenhausreport 2020 legt Evidenz vor
                                • Verbesserte medizinische Versorgung für Mädchen und Frauen mit Genitalverstümmelung
                                • Liquid Biopsy: Triage von Lungenkrebspatient*innen mit Hilfe zell-freier Tumor-DNA in Blutproben
                                • Remdesivir (Veklury®, Gilead) bei Covid-19
                                • Hochfrequente Rückenmarkstimulation für Erwachsene mit chronischen, nicht krebsbedingten Schmerzen.
                                • Termine
                                • Themen-Vorschau
                                Print Zur Druckversion...
                                Adobestock-329115246-von-mike-fouque-klein7
                                @ Mike Fouque

                                Announcement

                                Covid-19: HSS/ Horizon Scanning Living Document (v07 October 2020)

                                The establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary. The products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.

                                All work steps are conducted in close international (European) cooperation.

                                Publications: 

                                • Policy Brief No. 002: http://eprints.aihta.at/1234/


                                Contact: Claudia Wild

                                More...

                                Newsletter_preview

                                Newsletter

                                Note: this content is only available in German.

                                Inhalt

                                • Orphan Drug Gesetzgebung: Unabhängige Evaluation belegt mit Fakten die längst identifizierten Problembereiche
                                • Horizon Scanning zu Gentherapien: CAR-T Zelltherapien und ATMPs
                                • Horizon Scanning in der Onkologie – Fact Sheets
                                • PET/PET-CT Evidenz zum Bedarf und zur Planung bei onkologischen Indikationen
                                • Mobil-O-Graph®: 24-Stunden Blutdruckmesser mit eingebautem ARCSolver® Algorithmus
                                • Termine
                                • Themen-Vorschau
                                Print Zur Druckversion...
                                Adobestock-329115246-von-mike-fouque-klein6
                                ©Mike Fouque

                                Announcement

                                Covid-19: HSS/ Horizon Scanning Living Document (v06 September 2020)

                                he establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary. The products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.

                                All work steps are conducted in close international (European) cooperation.

                                Publications: 

                                • Policy Brief No. 002: http://eprints.aihta.at/1234/
                                • EUnetHTA Remdesivir Report


                                Contact: Claudia Wild

                                More...

                                « < 1 2 3 4 5 ... > »
                                Displaying results 11 to 20.
                                • News
                                  • Announcements
                                    • Events
                                      • Newsletter
                                        • Press photos
                                        • About us
                                          • Evaluation
                                            • History
                                              • Methods
                                                • Team
                                                  • Shareholder & organization chart
                                                    • Stakeholder involvement
                                                      • Press clippings
                                                      • Research areas
                                                        • Oncology
                                                          • High tech medicine
                                                            • Rehabilitation and occupational therapy
                                                              • Prevention and screening
                                                                • Psychological & psychiatric interventions
                                                                  • Health economics
                                                                    • European collaboration
                                                                      • HTA-methods & steering instruments
                                                                        • Complementary medicine
                                                                        • Research Projects
                                                                          • Synopsis of current research projects
                                                                            • Synopsis of completed research projects
                                                                              • Horizon Scanning in Oncology - Reports and Fact Sheets
                                                                                • Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
                                                                                  • Horizon Scanning in Oncology – support for a budget-impact-calculation
                                                                                    • Evaluation of individual medical procedures - Reports
                                                                                      • All projects in an overview
                                                                                      • Publications
                                                                                        • Repository
                                                                                          • HTA-Newsletter
                                                                                            • Annual Reports
                                                                                            • Search
                                                                                              Netzwerk
                                                                                              • Eunethta
                                                                                              • Ebm
                                                                                              • Inahta
                                                                                              • Dexhelpp
                                                                                              Shareholder
                                                                                              • Bmfg
                                                                                              • Sv
                                                                                              • Wgfond
                                                                                              • Noe
                                                                                              • Ooghfond
                                                                                              • Ghls
                                                                                              • Tirol
                                                                                              • Vorarlberg
                                                                                              • Kghfond
                                                                                              • Ghpf
                                                                                              • Burgef
                                                                                              • Contact
                                                                                                • Imprint
                                                                                                  • Privacy Notice
                                                                                                    • Newsletter
                                                                                                      • Sitemap
                                                                                                        © 2021 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                        • Log in